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Abstract
The wound microbiome may play an important role in the wound healing process.
We conducted the first systematic prognosis review investigating whether aspects of
the wound microbiome are independent prognostic factors for the healing of complex
wounds. We searched Medline, Embase, CINAHL and the Cochrane Library to
February 2019. We included longitudinal studies which assessed the independent
association of aspects of wound microbiome with healing of complex wounds while
controlling for confounding factors. Two reviewers extracted data and assessed risk of
bias and certainty of evidence using the GRADE approach. We synthesised studies
narratively due to the clinical and methodological heterogeneity of included studies
and sparse data. We identified 28 cohorts from 21 studies with a total of 38,604 par-
ticipants, including people with diabetes and foot ulcers, open surgical wounds, venous
leg ulcers and pressure ulcers. Risk of bias varied from low (2 cohorts) to high
(17 cohorts); the great majority of participants were in cohorts at high risk of bias.
Most evidence related to the association of baseline clinical wound infection with
healing. Clinical infection at baseline may be associated with less likelihood of wound
healing in foot ulcers in diabetes (HR from cohort with moderate risk of bias 0.53, 95%
CI 0.33 to 0.83) or slower healing in open surgical wounds (HR 0.65, 95% CI 0.51 to
0.83); evidence in other wounds is more limited. Most other associations assessed
showed no clear relationship with wound healing; evidence was limited and often
sparse; and we documented gaps in the evidence. There is low certainty evidence that
a diagnosis of wound infection may be prognostic of poorer healing in foot ulcers in
diabetes, and some moderate certainty evidence for this in open surgical wounds. Low
certainty evidence means that more research could change these findings.
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1 | INTRODUCTION
Complex wounds heal by secondary intention—that is by the
formation of new tissue rather than by the approximation of the
wound edges (primary intention).1 Complex wounds include pressure,
leg, and foot ulcers, and open surgical wounds that, despite different
aetiologies, share a common risk of infection and slow healing. These
wounds are all usually managed with dressings, although other treat-
ments vary (eg, venous leg ulcers are treated with compression and
pressure ulcers with repositioning and specialist support surfaces).2
In 2011, the point prevalence of complex wounds in the United
Kingdom was estimated at 1.47 (1.38-1.56) per 1000 of the popula-
tion, this figure being inferred from a large multiservice cross-sectional
study of a single city (Leeds, population c. 750,000).1 The most fre-
quently documented wounds were pressure ulcers and leg ulcers.
Complex wounds take a substantial—but variable—time to heal,
impose a considerable burden on people living with them and also
have a societal and cost impact in lost activity and medical expendi-
ture.3 People with complex wounds report that complete wound
healing is the most important outcome to them.1
There are many potential risk factors or predictors for whether a
complex wound will heal and how long this might take. Candidate fac-
tors can broadly be grouped as being at: the population level, the indi-
vidual level, the whole wound level and the cellular level. Prognostic
factors at each of these levels are likely to be inter-related in often
complex and bidirectional relationships between predictive factors.4
For example, known factors associated with the future healing of
venous leg ulcers include wound size and wound duration at study
entry5 which may also predict pressure ulcer healing.6 Such factors do
not, however, explain much of the observed variation in healing tra-
jectory, and may themselves have a bidirectional relationship with
other factors such as the wound microbiome.7 Elucidating indepen-
dent relationships between prognostic factors and wound healing
requires carefully designed studies which collect a range of clinical,
biochemical and microbiological data.
All open wounds contain bacteria: initial colonisation is usually by
commensal species from the skin with the potential to acquire or acti-
vate virulence factors.8 Subsequent colonisation of wounds by patho-
genic species is also a risk in open wounds.9 Bacteria are often
believed to be present in wounds in the form of biofilms.10 Biofilms
are generally defined as microbial cells surrounded by a polymer
matrix of microbial and/or host origin, that adhere to surfaces or to
themselves. Growing in this way can make bacteria more tolerant to
bactericidal agents.11,12
There are many possible associations between elements of the
wound microbiota and wound progress including how long wounds
take to heal completely. Suggested prognostic factors include the
overall number of microbes (microbial load or bioburden)13; the spe-
cific types of bacteria (including drug-resistant characteristics) in the
wound,14 and/or inter-bacterial interactions15 and characteristics of
resulting biofilms.16 Most wounds heal despite the presence of
microbes17 so it has been suggested that the balance between bacte-
rial activity and the responsiveness of the host immune system is
likely to be of key importance.18 This develops an earlier concept of
critical colonisation, a precursor to clinical infection19; this state is
often considered, by rather circular reasoning, to be indicated by del-
ayed healing. Diagnosis of infection by contrast usually requires the
additional presence of one or more clinical signs such as local pain,
heat, redness, swelling and secretion of pus.
Whilst there has been research on the association of the wound
microbiome and healing, empirical evidence in this area has not been
systematically reviewed. The Australian Wound Management Associa-
tion states that ‘the true extent of bacterial impairment of wound
healing is unknown’.20 Whilst prognostic association of the micro-
biome and healing has not been systematically reviewed, there are
several treatments available which are suggested to promote healing
based on purported antimicrobial activity, for example, silver dress-
ings.21 Use of these treatments in wounds without clinical infection is
predicated on there being a relationship between reducing bacterial
load (and perhaps preventing infection) and the wound healing trajec-
tory. Evidence for the effectiveness of these treatments is also
unclear.22 Finding a predictive relationship between aspects of the
wound microbiome and wound healing may not necessarily indicate a
causal relationship but may, nevertheless, allow better identification
of wounds which are likely to show poor healing. Scoping work indi-
cated that the relevant literature was likely to be sparse and diverse,
and this supported a decision to adopt broad objectives and inclusion
criteria for this review.
1.1 | Objective
To determine whether aspects of the wound microbiome are indepen-
dently prognostic for wound healing in people with the following
types of complex wounds: pressure ulcers, venous leg ulcers, foot
ulcers in people with diabetes, or surgical wounds healing by second-
ary intention.
2 | MATERIALS AND METHODS
The full protocol for this systematic review was registered on PROS-
PERO and has the registration number CRD42019136141.23
2.1 | Inclusion criteria
We included prospective or retrospective longitudinal studies, includ-
ing those based on registry data (data collected through an organised
registry system on patients with a common condition), which assessed
whether a relevant potential bacterial prognostic factor was associ-
ated with healing in complex wounds in humans. Case–control studies
would have been included in the absence of other studies for a partic-
ular prognostic factor association with the outcome.
We only included studies which aimed to measure the indepen-
dent association with healing of one or more prognostic factors while
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controlling for other factors by use of a multivariable analysis or other
appropriate method such as the use of propensity matching in the
study design. Studies reporting only univariate analyses were noted
but not included in the review.
In some cohorts, study authors undertook a multivariable analysis,
and applied prespecified criteria for the inclusion of variables in their
multivariable analyses. This could mean that the potential bacterial
prognostic factor was not included in the final multivariable analysis
because its association with healing did not reach criteria for
significance—a potentially important finding. We therefore included
all studies which carried out multivariable analyses where at least one
potential bacterial prognostic factor was considered, including where
the variables of interest to our review did not meet the criteria for
multivariable analysis. Where this was the case, we noted that vari-
ables did not meet criteria for inclusion in the multivariable analysis
and, if possible, reported the univariate associations. We considered
the appropriateness of the criteria used to determine which variables
were included in the multivariable analyses as part of our risk of bias
assessment. Similarly, where there were primary outcome data for an
association, we noted studies reporting only our secondary outcome
of change in wound size, but did not analyse these.
Complex wounds were defined as: foot ulceration in people with
diabetes (Wagner grade I or above); venous or mixed aetiology leg ulcers;
pressure ulcers (stage II or above); surgical wounds healing by secondary
intention (open surgical wounds). We did not further limit eligibility and
included studies in which at least 75% of participants had a relevant
wound. We excluded studies of burn wounds, which often heal by sec-
ondary intention but are outside the scope of this review because of the
specific immunological issues associated with burn injuries.
We considered the following types of potential bacterial prognos-
tic factors: Bioburden: Presence or absence of wound infection, how-
ever defined; other measures of bioburden including quantification of
colony forming units, assessment of critical colonisation, or detectable
biofilm measurement. Bacterial typology: Diversity measured by the
number of different strains or species; the presence of particular types
of bacteria such as Gram-positive or Gram-negative; anaerobic spe-
cies; the presence of bacteria with characteristics such as multi-drug
resistance; the presence of particular strains of bacteria including but
not limited to those identified as pathogens. Response to treatment:
responses to antimicrobial treatment including changes in any previ-
ously specified aspect of the microbiome. We accepted study author
definitions of potential prognostic factors because we anticipated
substantial heterogeneity in the literature.
Any approach to obtaining samples from wounds and any method
of measurement of prognostic factors was permitted, but we excluded
measures of bacterial presence taken from extra-wound sources such
as blood samples or biopsies from other locations.
2.1.1 | Outcomes
Primary outcomes were time to wound healing (survival analysis) and
proportion of healed wounds at any specified timepoint. An
association ratio measure less than 1 indicated a risk of poorer healing
(fewer wounds healed or longer time to healing) when the potential
prognostic variable was present.
The secondary outcome was the surrogate outcome of change or
rate of change in wound size; we planned to analyse these secondary
outcome data only if no primary outcome data were available for an
association. As our primary outcome was reported for all associations
analyses of secondary data are reported in Supporting Information
Tables.
2.1.2 | Search
We searched the following databases in February 2019: Ovid Medline
(from 1946), Ovid Embase (from 1946), CINAHL (from 1982) and
Cochrane Central Register of Controlled Trials. We also checked the
references of included studies and identified systematic reviews.
Details of the search strategy are provided in the Appendix.
2.1.3 | Selection of studies, data extraction and
risk of bias and quality assessment
Data were extracted by one review author and checked by a second
using a standardised data extraction sheet (piloted on a small number of
studies). We extracted data on the following: country and setting, study
design, eligibility criteria, participant baseline characteristics, treatment
regimen, sampling method(s), prognostic factor with measurement and
assessment methods, outcome data and measurement, follow-up dura-
tion, analysis details including adjustment (potential confounding) factors,
association statistics with measures of variance, losses to follow-up. We
extracted adjusted and, where appropriate, unadjusted measures of asso-
ciation and planned to convert effect sizes as necessary. Confounding
factors were also considered as part of the risk of bias assessment.
Risks of bias were independently assessed by two review authors
using the Quality in Prognosis Studies (QUIPS) tool.24 Any disagree-
ments were resolved through discussion and consensus. The QUIPS
tool considers the following six domains: representative population,
missing data, prognostic factor measurement, outcome measurement,
confounding factors, analysis and reporting. We assigned overall risks
of bias as low, moderate or high based on predetermined criteria
across all assessed domains. Associations were considered to have a
low risk overall risk of bias where all domains were low risk or where
one was moderate but the rest were low; where two or more domains
were at moderate risk of bias and none at high risk the overall risk of
bias was considered to be moderate; where one or more domains was
at high risk of bias the overall risk of bias was considered to be high.
For each study we summarised the results of the risk of bias assess-
ment for each domain, and overall, in a table (see Supporting Informa-
tion Tables); a full assessment which includes the comments for each
study for each domain is available on request from the authors.
We used a modified GRADE framework to assess the quality of
evidence for each prognostic factor–outcome combination.25 GRADE
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assessments were carried out by one review author and checked by a
second; disagreements were resolved through discussion and consen-
sus. GRADE takes into account the results of the risk of bias assess-
ment of contributing studies, but also whether there is imprecision,
inconsistency, indirectness or publication bias in the evidence for each
association. Evidence may be graded as high, moderate, low or very
low certainty based on the assessment. In some cases we adopted a
flexible approach where areas of concern across multiple domains
were aggregated to produce a single downgrade; this approach is
supported by the GRADE working group.26 GRADE judgements for
each association, their rationale and the evidence on which they are
based are summarised in the Summary of Findings Tables (see
Supporting Information). Where evidence varied in completeness,
we gave precedence to the results of cohorts with fully reported
adjusted effect estimates for the association in determining the
GRADE assessment; whilst considering the congruence of this data
with that from studies with incomplete reporting. Where we needed
to select an effect estimate for the Summary of Findings Table we
gave priority to cohorts with low or moderate risk of bias over those
with high risk of bias, while acknowledging the results of higher risk
cohorts.
2.1.4 | Data synthesis
We conducted a narrative synthesis supported by structured
tables, with evidence from studies grouped, as planned in the pro-
tocol, by the prognostic factor reported, the baseline infection sta-
tus and the wound aetiology, because of the clinical relevance of
these factors and the likely different treatment regimens in prac-
tice We had planned to implement a random-effects meta-analytic
approach where appropriate23 however, due to the clinical and
methodological heterogeneity of the prognostic variables and the
often limited reporting of the data this was not possible. Where
appropriate we have presented studies using forest plots but have
not calculated pooled association statistics. Because of the dispa-
rate and sparse nature of the data we have also mapped the
evidence and the gaps in the evidence graphically. In the body of
the paper we have prioritised presenting detailed evidence summa-
ries in the text for potential prognostic factors with most clinical
salience (eg, infection and presence of organisms with resistant
characteristics) and those for which the evidence may be more
generally applicable in a clinical setting (broader groupings such as
anaerobic bacteria, pathogenic bacteria or Gram-negative or
-positive bacteria). We have fully documented the evidence for all
individual species in the Supporting Information and have provided
a summary of those for which there was low certainty evidence
(as opposed to very low certainty evidence) reported by more than
one cohort.
3 | RESULTS
We identified 28 cohorts from 21 studies (in 23 publications) for
inclusion in the review; together these report data on 38,604 partici-
pants.4,6,13,17,27-43 Some studies reported on more than one cohort
(cohorts with different wound aetiologies or RCT treatment groups
analysed as cohorts). These studies were identified from screening of
913 records following deduplication of the searches; we identified a
further six studies from reference checking and assessed 272 studies
as full text. In addition to the 21 included studies, there were 22 stud-
ies which would otherwise have met the inclusion criteria but did not
contain any multivariable analysis or use any other appropriate
methods (see Appendix). The review process is documented in the
PRISMA diagram (Figure 1).
3.1 | Characteristics of cohorts
The characteristics of the included cohorts are summarised in
Figure 2. Figure 2(A) summarises characteristics by wound aetiology
and Figure 2(B) summarises the same cohorts but by baseline infec-
tion status. Detailed information on the characteristics of the cohorts
is shown in Table S1.
F IGURE 1 Study flow diagram (PRISMA diagram) [Color figure can be viewed at wileyonlinelibrary.com]
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Of the 28 cohorts, 15 had a prospective cohort study design or
were RCTs analysed as cohort studies, and the remainder were retro-
spective cohorts, or drawn from retrospectively analysed registry
data. Of the 38,604 participants who contributed data to this review
90% (34,675) were from six cohorts using registry data; analyses
of these data were reported in three overlapping studies.4,6,35
Most other studies were small (total participants 3929; median 136;
range 64–1340).
Twenty-two of the 28 cohorts included participants whose
wounds had mixed infection status at baseline (some participants had
infected wounds at baseline and some had non-infected
wounds).4,6,31-43 This represents the overwhelming majority of partici-
pants (Figure 2(B)). Most cohorts of participants with mixed infection
status wounds assessed the role of clinical infection (variously
defined) as a prognostic factor for healing (Figure 3). While all four
wound aetiologies were well represented in terms of total participant
numbers they varied in the source of data and only registry data (for
which reporting was limited) were available for pressure ulcers
(Figure 2(A)).
In six smaller cohorts, of people with foot ulcers in diabetes or
venous leg ulcers, infection was used as an inclusion or exclusion cri-
terion and the studies assessed a wide range of relevant bacteria-
related prognostic factors. Four cohorts (446 people) included only
people with wounds which were not infected at baseline.13,17,27,28
Two cohorts (both in people with diabetes and foot ulcers; 487 partici-
pants) enrolled only people with wounds which were infected at
baseline.29,30
There was considerable variation in how healing was reported in
cohorts including the time to complete healing, the proportion of
wounds completely healed at a given follow-up and change in wound
area (a secondary review outcome and not analysed where primary
outcome was reported). Follow-up duration varied considerably, rang-
ing from 10 weeks to 1 year. The adjusting variables taken into con-
sideration in the multivariable analyses also varied in number and
type; most studies used some demographic and some wound charac-
teristics; age and wound size at baseline were the most common. Sev-
eral studies looked at a large number of potential factors in initial
analyses and employed prespecified rules on significance for those
used in subsequent multivariable analyses. The consideration of
appropriate confounding factors formed part of our assessment of risk
of bias for each association. Details are given in Tables S2–S5.
3.2 | Quality of the evidence
We assessed the overall quality of the evidence using the GRADE
approach for prognostic factor evidence.25 Risk of bias was one ele-
ment considered in the quality assessment and this varied; nine
cohorts were considered to produce findings at moderate risk of bias
but two cohorts produced findings judged at low risk,40,42 and
17 cohorts (from 10 reports) produced findings judged at high risk of
bias.4,6,13,27,28,33,35,36,39,43 The great majority of participants were in
the majority of cohorts judged to produce findings at high risk of bias.
A summary of the QUIPS assessment is shown in Table S2. The
domain which was most commonly judged to be at high risk of bias
was analysis and reporting, whilst that most rarely judged to be at high
risk of bias was prognostic factor measurement; high risk of bias was
equally common across the other four domains. Inclusion of appropri-
ate confounding factors is one of these domains and cohorts reported
adjusting for a range of factors at the level of the participant and the
wound. Age and gender were the most common person-level factors,
while wound duration and measures of wound size were the most
common wound level factors. Full details are given in Tables S3–S5.
As previously noted, evidence was also assessed for inconsis-
tency, imprecision, indirectness and publication bias. Evidence for
most of the prognostic factors evaluated was downgraded at least
once for risk of bias; other downgrading decisions varied but almost
all evidence was assessed as either low or very low certainty, with
many associations downgraded at least once for imprecision. Publica-
tion bias was considered likely in evidence for the association
between infection and wound healing.
3.3 | Association between baseline wound
infection status and healing
Seventeen cohorts (36,472 participants) assessed the association
between baseline wound infection (presence or absence of infection,
defined in various ways) and wound healing, assessed as either pro-
portion of wounds healed or time to complete healing.31-35,42 Data
could not be pooled and are presented narratively and summarised in
Figure 3; further details are in Table S3. Figure 3 also contains GRADE
assessments for the evidence for each wound aetiology and the full
assessments are summarised in Summary of Findings tables in
Supporting Information.
Definitions of infection were not given in several instances. Other
cohorts reported that presence of one or two key indicators was used
to determine infection status. (Table S3). A minority of studies used
established definitions of wound infection or supplied detailed criteria
for this.
A large proportion of the data derived from cohorts with a high
risk of bias, and a majority of participants were in cohorts with limited
reporting of adjusted effect estimates for the association between
infection and healing: several cohorts only reported P-values or other
summary data which could not meaningfully be interpreted in the
absence of additional data. Reported data are shown in Table S3. As
outlined, we prioritised data from fully reported adjusted analyses,
where these were available, in forming our GRADE assessments, while
taking into account the agreement with evidence from other cohorts
and their data.
Adjusted analyses with numerical results for associations were
reported for four cohorts with 1229 participants. Of these 393 partici-
pants (one cohort) had open surgical wounds and 836 (three cohorts)
had foot ulcers and diabetes (Figure 4). All four cohorts reported
adjusted estimates showing an association between wound infection
and reduced likelihood (risk) of healing.
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F IGURE 2 Map of evidence distribution by (A) Wound etiology and (B) Baseline infection status
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The cohort in open surgical wounds was considered to be at low
risk of bias (adjusted HR for likelihood (risk) of healing if wound
infected 0.65; 95% CI 0.51 to 0.83), and this was affected by indirect-
ness as not all infections were present at baseline measurement;
it was unclear if infection timing was considered in the analysis.
This is moderate certainty evidence (downgraded once for indirect-
ness) that wound infection in an open surgical wound probably
reduces the likelihood of healing.
One of the cohorts in people with foot ulcers was at moderate
risk of bias (118 participants; adjusted HR 0.53; 95% CI 0.33 to 0.83).
The other two cohorts (204 participants) were at high risk of bias and
we were very uncertain about the reliability of the reported analyses.
This is low certainty evidence which was downgraded twice for high
risk of bias impacting most of the participants.
Four cohorts of people with foot ulcers in diabetes (342 partici-
pants) reported unadjusted association measures or data to allow calcu-
lation of these.33,34,43 These results were not consistent with the
studies which reported adjusted effect measures; all except one cohort
had confidence intervals which included the possibility of benefit as
well as harm to infected status. It is possible that, in addition to impreci-
sion from low numbers of participants/events, the role of treatments in
the cohorts drawn from an RCT may have been a factor in this.33
Studies which reported only P values almost all reported statisti-
cally significant values for the association between infection and
F IGURE 3 Map of evidence for infection as a potential prognostic factor for wound healing [Color figure can be viewed at
wileyonlinelibrary.com]
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healing. This included the very large registry cohorts. Whilst these
data are subject to very high risks of bias, they represent large num-
bers of participants and show effects which align with those from the
fully reported multivariable analyses. In addition to reporting issues in
the cohorts which reported only p values we consider that there is
potential for publication bias, with small studies which did not find
clear evidence for an association between infection and healing possi-
bly missing from the published literature. This should be taken into
consideration when assessing the certainty of the evidence.
In summary, there is low certainty evidence for an association
between wound infection at study baseline and subsequent poorer
healing (defined as a longer time to heal or a lower probability of
healing) for foot ulcers in people with diabetes and some moderate
certainty evidence for this association in open surgical wounds, based
on those studies with a fully reported adjusted effect size (Figure 3),
and taking other studies into consideration. Evidence for the associa-
tion between infection and healing in pressure ulcers or venous leg
ulcers is uncertain (very low certainty) because of the combined
impact of high risks of bias, imprecision and potential publication
bias.44 We consider the evidence for an association between wound
infection and a reduced likelihood (risk) of healing across all wound
types to be low certainty, taking into account all the cohorts which
contributed evidence. The evidence and the GRADE assessments
for certainty are summarised in the Summary of Findings
Table (Supporting Information).
3.4 | Other bacterial prognostic factors for wound
healing
A wide range of other potential prognostic factors were assessed, pri-
marily in studies which enrolled only people with infected foot ulcers
in diabetes or only people with uninfected venous leg ulcers or foot
ulcers at baseline. These potentially prognostic factors can be broadly
summarised as bacterial load; bacterial diversity; the presence of
specific types of bacteria either at the level of broad characteristics
(eg, pathogens; anaerobic; Gram-positive; Gram-negative) or the phy-
lum, family, genera, species or subspecies. Many of these data were
limited by being at high risk of bias as well as imprecision.
We have mapped the prognostic evidence for the listed micro-
biome factors and wound healing risk by wound type and wound
infection status (Figure 5), data for family, genera, species or subspe-
cies is presented narratively. None of the potential prognostic factors
assessed showed a clear association with the likelihood (risk) of
healing. As Figure 5 demonstrates, the evidence available on which to
base inference is limited: no data are available for pressure ulcers and
very little is reported for open surgical wounds. There is more infor-
mation for associations of these microbiome wound factors with
healing in venous leg ulcers and foot ulcers in people with diabetes,
but most associations are represented by a single cohort. Risk of bias
varied from low to high, but almost all associations were affected by
substantial imprecision, leading to the evidence being downgraded
twice which means that evidence was low certainty and, where
there was also high risk of bias, very low certainty. Details of the
adjusted analyses for each potential prognostic factor are given in
the Appendix and Tables S4 and S5. The evidence and the GRADE
assessments for certainty are summarised in the Summary of Find-
ings Table (Supporting Information).
3.5 | Individual families and species of
microorganisms
Studies assessing individual families or genera of microorganisms
looked at both infected and uninfected wounds and included foot
ulcers in people with diabetes, venous leg ulcers and post-amputation
open surgical wounds. Adjusted estimates were reported only for foot
ulcers in diabetes. Most evidence was low or very low certainty
(downgraded for imprecision in each case, and in some cases also for
high risk of overall bias). Full details are given in Table S5 and the
F IGURE 4 Forest plot of cohorts with reported or calculated effect estimates for the association of infection with poorer healing. Favours no
infection means that hazard/risk/odds of healing is increased when there is no infection [Color figure can be viewed at wileyonlinelibrary.com]
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Supporting Information; we discuss evidence where there were
adjusted effect estimates and low certainty evidence.
The great majority of the species assessed as potential prognostic
factors did not show a clear association with healing in any type of
wound. The exception was coagulase-negative Staphylococcus, where
a cohort of 299 people with baseline infection of foot ulcers in diabe-
tes found low certainty evidence that there may be an association
with longer time to complete healing (adjusted HR for healing 1.53;
95% CI 0.98 to 2.40).29 This was low certainty evidence downgraded
twice for imprecision.
The most commonly assessed species was Staphylococcus aureus
where the association with healing was assessed in six cohorts
(801 participants), followed by strains of Streptococcus (five cohorts,
731 participants)17,29,39-41; and Pseudomonas (five cohorts, 711 partici-
pants).27,29,39-41 Adjusted effect estimates were available for S. aureus
for two cohorts (393 participants)17,29; for Streptococcus these two
cohorts also reported adjusted effects,17,29 while for Pseudomonas
only a single cohort (299 participants) did so.29 In each case adjusted
effect estimates were available only for foot ulcers and there was low
certainty evidence of no clear association of the bacteria with the like-
lihood (risk) of healing. The certainty of the evidence was downgraded
twice for imprecision. Other species or groups were assessed only by
single cohorts.
4 | DISCUSSION
4.1 | Summary of the evidence
To the best of our knowledge this is the first systematic review of
microbiological potential prognostic factors for complex wound
healing. We developed our protocol prior to the publication of the
F IGURE 5 Map of evidence for characteristics of wound microbiome as potential prognostic factors for wound healing [Color figure can be
viewed at wileyonlinelibrary.com]
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SWiM guidelines for synthesis without meta-analysis,45 however our
approach follows many of the same principles of transparency. We
considered a wide range of factors, from a diagnosis of clinical wound
infection to the presence of individual species.
We identified 21 studies reporting on 28 cohorts; most were pro-
spective studies but a minority including six cohorts of registry data
were retrospective. GRADE assessments judged almost all the evi-
dence to be low or very low certainty, largely due to high all-domain
risks of bias and imprecision.
There was some moderate certainty evidence that a diagnosis of
wound infection may be prognostic of poorer healing in open surgical
wounds and low certainty evidence in foot ulcers in diabetes.
Across wound aetiologies the evidence is low certainty. Low certainty
evidence means that more research could change these findings. Find-
ings for almost all other bacterial prognostic factors assessed showed
no clear relationship with wound healing, or too much uncertainty to
determine if there was a relationship.
4.1.1 | Mixed wound infection status studies
Cohorts that recruited people with wounds that could be either
infected or noninfected at baseline generated the majority of partici-
pants in this review. Infection is consistently associated with a lower
likelihood of complete healing/longer time to complete healing in mul-
tivariable analyses in foot ulcers in people with diabetes and in open
surgical wounds. However, effect sizes and definitions of infection
varied or were absent, and the certainty of the evidence is reduced by
the high risks of bias in many studies, by incomplete reporting, and by
indirectness. Publication bias is considered likely in prognosis research
and is probably an additional limitation for this association across
wound types.44 Another limitation was the fact that several studies
did not report how they defined wound infection in their baseline
assessment (see Tables S2 and S3). The evidence for wound infection
being prognostic for wound healing had very low certainty in pressure
ulcers and venous leg ulcers.
In determining the certainty of the evidence we considered
carefully whether observed association sizes should prompt
uprating of the evidence for moderate or large effect size, but the
studies which might have given rise to this decision were at high
risk of bias in more than one domain and the risk of bias might have
led to inflated association statistics sizes. Evidence from these
mixed infection status cohorts for other potential prognostic fac-
tors was very limited.
4.1.2 | Wounds infected at baseline
Where wounds are infected at baseline, studies evaluated several
potential microbiological prognostic factors in foot ulcers in diabe-
tes including the presence of multiple individual genera or species
of bacteria but, in most cases, the there is no clear association with
healing. This is low certainty evidence because of imprecision.
There is no evidence for any other type of wound where there is
baseline infection.
4.1.3 | Wounds without baseline infection
In wounds without an infection at baseline, studies also evaluated
several potential microbiome-related prognostic factors in foot ulcers
in diabetes, including bacterial load and diversity as well as individual
genera or species but in no case did any study find a clear association
with healing. There is very limited and uncertain evidence in venous
leg ulcers without baseline infection. There were no studies assessing
potential prognostic factors in any other type of wound where there
is no baseline infection.
4.2 | Relationship of the evidence base to clinical
practice
There are many potential microbiological prognostic factors for
wound healing in complex wounds. The studies we identified collec-
tively assessed a large number of these. In almost all cases there was
no clear association, or too much uncertainty to determine if there
was an association, between the potential factor and wound healing.
The exception is evidence that clinical infection is associated with
poorer healing for foot ulcers in diabetes (low certainty) and open sur-
gical wounds (moderate certainty) but even this may be affected by
publication bias. Even though this is low certainty evidence, consid-
ered across all wound types, the taking of steps to prevent wound
infection remains clinically important for a range of reasons. Treating
infections clearly also remains important.
Whilst wounds that are infected may be at increased risk of poor
healing, this association requires further exploration and findings of
this work might guide future development of treatment regimes. It is
important to note that an association between a prognostic variable
and an outcome does not imply that there is a causal relationship.46
Clinical wound infection may be reflective of a sub-optimal wound
status at baseline rather than a cause of it. Although the included
studies adjusted for some factors in their analyses it is highly likely
that underlying issues at the level of the wound or person played a
role in determining both susceptibility to infection and healing trajec-
tory in the wounds evaluated. We know that there is limited evidence
for the effect of antimicrobial treatments on healing in the types of
complex wounds included here.22,47 We did not identify any studies
that looked at the relationship between microbiological responses to
treatment and wound healing, although antibacterial treatments were
used and adjusted for in analyses in studies in infected wounds.
It has been proposed that other features of wound microbiomes
(bacterial load, diversity and presence of particular types of bacteria
or resistant strains of bacteria) may be predictive of or responsible for
poor healing of complex wounds.19 The evidence we identified was
relatively limited and what data were available on potential factors
assessed showed no clear relationship with wound healing. In
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particular, we did not find evidence to support a prognostic relation-
ship of nonclinical wound features such as the concept of “critical col-
onisation” with wound healing. Bacterial load and bacterial diversity
were assessed only in wounds without baseline infection and, in each
case, there was limited evidence which did not show clear associations
between load.13,17 We identified only one study which specifically looked
at colonisation,39 and one which looked at presence of biofilm.34 In both
cases there were issues with the way in which these potential prognostic
factors were assessed. There were no data which addresses whether “crit-
ical colonisation” may be associated with poorer healing, and the data on
bacterial load were imprecise, being drawn from small cohorts.
This summary of the evidence shows that we do not know with
any certainty whether the load or variety of bacteria, or the presence
of particular groups of bacteria in complex wounds is independently
associated with the healing of those wounds. Low numbers of partic-
ipants contributed to substantial imprecision around most measures
of association, and in many cases the data came from studies at high
risk of bias. Our findings are in line with guidance which suggests
restricting use of many antimicrobial dressings to wounds with clini-
cal infection.2
There is a particularly clear gap in the evidence for possible
microbiological prognostic factors for the healing of pressure
ulcers, especially given that the healing trajectory for these wounds
can be slow and difficult to predict once mechanical factors are
controlled for. We have limited evidence for the effect of factors
other than clinical infection on healing in other complex wounds.
There is also a clear need for more-well-conducted and reported
studies of potential microbiological prognostic factors in complex
wounds including foot ulcers. Longitudinal studies which assess
both the response of the wound microbiome to antimicrobial treat-
ment and the time to wound healing would help to inform our
understanding of the relationship between bacterial factors and
healing processes. While these studies would improve our under-
standing of what may predict poor wound healing it is important to
remember that they would not address the question of whether
there is a causal relationship of aspects of microbiology with
healing; as with infection, other microbiological features may also
reflect underlying factors such as reduced immunological response
or poor perfusion, which also lead to reduced healing.48
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